Stocktoria
Sonoma Pharmaceuticals, Inc. SNOA
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2007-01-26
Sonoma Pharmaceuticals, Inc. financials (annual, from 10-K)
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $19.5M | $14.3M | $12.7M | $13.3M | $12.6M |
| Gross profit | $7.4M | $5.5M | $4.7M | $4.5M | $4.0M |
| R&D expense | $2.3M | $1.8M | $1.9M | $207,000 | $125,000 |
| SG&A expense | $7.6M | $7.4M | $7.6M | $8.8M | $9.8M |
| Operating income | -$2.5M | -$3.7M | -$4.7M | -$4.6M | -$5.9M |
| Income tax | -$244,000 | $550,000 | -$196,000 | -$33,000 | -$332,000 |
| Net income | -$3.2M | -$3.5M | -$4.8M | -$5.2M | -$5.1M |
| EPS (diluted) | $-1.89 | $-2.79 | $-10.63 | $-1.52 | $-1.92 |
| Operating cash flow | -$3.9M | -$88,000 | -$2.4M | -$6.2M | -$4.2M |
| Free cash flow | -$4.1M | -$168,000 | -$2.4M | -$6.4M | -$4.4M |
| Cash & equivalents | $2.4M | $5.4M | $3.1M | $3.8M | $7.4M |
| Inventory | $3.7M | $2.9M | $2.7M | $2.9M | $2.7M |
| Total assets | $14.0M | $13.7M | $14.7M | $16.2M | $18.8M |
| Total liabilities | $10.9M | $9.3M | $8.6M | $8.3M | $10.1M |
| Shareholders' equity | $3.1M | $4.4M | $6.1M | $8.0M | $8.7M |
Source: SEC EDGAR filings · CIK 0001367083 · as of 2026-03-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.